Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Sentinel Oncology

    Client Virtual Booth

    SENTINEL ONCOLOGY

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Sentinel Oncology
    unitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Sentinel Oncology Limited 20 Station Road, Cambridge CB1 2JD
    Telephone
    Telephone
    +44 (0)1223 653 209
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sentineloncology.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sentinel-oncology-limited
    Twitter
    Twitter
    https://twitter.com/senoncology

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    The McQuade Center Enters Agreement with Sentinel Oncology
    The McQuade Center Enters Agreement with Sentinel Oncology

    https://www.businesswire.com/news/home/20210902005442/en

    BUSINESSWIRE
    02 Sep 2021
    Share Share
    PharmaEngine,and Sentinel Oncology Limited Enter into an Exclusive Collaboration
    PharmaEngine,and Sentinel Oncology Limited Enter into an Exclusive Collaboration

    https://www.prnewswire.com/news-releases/pharmaengine-inc-and-sentinel-oncology-limited-enter-into-an-exclusive-collaboration-and-license-agreement-for-sol-578-a-chk1-inhibitor-301186436.html#:~:text=(TWO%3A%204162)%20announced%20today,enabling%20studies%20for%20SOL%2D578.

    PRNEWSWIRE
    04 Dec 2020
    Share Share
    PharmaEngine, & Sentinel Oncology Limited Enter into SOL-578
    PharmaEngine, & Sentinel Oncology Limited Enter into SOL-578

    https://www.prnewswire.com/news-releases/pharmaengine-inc-and-sentinel-oncology-limited-enter-into-an-exclusive-collaboration-and-license-agreement-for-sol-578-a-chk1-inhibitor-301186436.html

    PRNEWSWIRE
    04 Dec 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search